Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Biochemical Journal
|
May 29, 2002
Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms
Nica M Borradaile, Linda E de Dreu, Lisa J Wilcox, et al.
The Journal of Biological Chemistry
|
June 22, 2002
Transcriptional profiling identifies two members of the ATP-binding cassette transporter superfamily required for sterol uptake in yeast
Lisa J Wilcox, Dina A Balderes, Brook Wharton, et al.
The Journal of Biological Chemistry
|
January 27, 2011
Loss of subcellular lipid transport due to ARV1 deficiency disrupts organelle homeostasis and activates the unfolded protein response
Caryn F Shechtman, Annette L Henneberry, Tracie A Seimon, et al.
Blood Advances
|
February 24, 2026
Safety, efficacy and patient-reported outcomes 6 years after fidanacogene elaparvovec in adults with hemophilia B
Benjamin J Samelson-Jones, John Ej Rasko, Jonathan Ducore, et al.
Therapeutic Advances in Hematology
|
June 29, 2026
Treatment preferences of people with hemophilia and caregivers: a plain language summary
Hui Lu, Travis Gould, Carmine Colavecchia, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 8, 2025
Patient and Caregiver Preferences for Long-Term Prophylactic Treatment of Bleeds in Haemophilia: A Discrete-Choice Experiment
Hui Lu, Travis Gould, Carmine Colavecchia, et al.
The Journal of Cell Biology
|
February 19, 2004
Mutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C-related protein reveals a primordial role in subcellular sphingolipid distribution
Krishnamurthy Malathi, Katsumi Higaki, Arthur H Tinkelenberg, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 19, 2025
Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trial
Kaan Kavakli, Adam Cuker, Laurent Frenzel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 20, 2025
Impact of Fidanacogene Elaparvovec Gene Therapy on Joint Health in Adults With Haemophilia B: Results From a Phase 3 Study
Davide Matino, Laurent Frenzel, Ali Bulent Antmen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Biochemical Journal
|
May 29, 2002
Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms
Nica M Borradaile, Linda E de Dreu, Lisa J Wilcox, et al.
The Journal of Biological Chemistry
|
June 22, 2002
Transcriptional profiling identifies two members of the ATP-binding cassette transporter superfamily required for sterol uptake in yeast
Lisa J Wilcox, Dina A Balderes, Brook Wharton, et al.
The Journal of Biological Chemistry
|
January 27, 2011
Loss of subcellular lipid transport due to ARV1 deficiency disrupts organelle homeostasis and activates the unfolded protein response
Caryn F Shechtman, Annette L Henneberry, Tracie A Seimon, et al.
Blood Advances
|
February 24, 2026
Safety, efficacy and patient-reported outcomes 6 years after fidanacogene elaparvovec in adults with hemophilia B
Benjamin J Samelson-Jones, John Ej Rasko, Jonathan Ducore, et al.
Therapeutic Advances in Hematology
|
June 29, 2026
Treatment preferences of people with hemophilia and caregivers: a plain language summary
Hui Lu, Travis Gould, Carmine Colavecchia, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 8, 2025
Patient and Caregiver Preferences for Long-Term Prophylactic Treatment of Bleeds in Haemophilia: A Discrete-Choice Experiment
Hui Lu, Travis Gould, Carmine Colavecchia, et al.
The Journal of Cell Biology
|
February 19, 2004
Mutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C-related protein reveals a primordial role in subcellular sphingolipid distribution
Krishnamurthy Malathi, Katsumi Higaki, Arthur H Tinkelenberg, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 19, 2025
Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trial
Kaan Kavakli, Adam Cuker, Laurent Frenzel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 20, 2025
Impact of Fidanacogene Elaparvovec Gene Therapy on Joint Health in Adults With Haemophilia B: Results From a Phase 3 Study
Davide Matino, Laurent Frenzel, Ali Bulent Antmen, et al.
Page
of 1